FDA Replaces Regulations With Just Visit Our Website
Published Date: 6/15/2026
Rule
Summary
The FDA is updating its rules to point everyone to its website for the latest contact and organizational info, ditching old, unnecessary regulations. This makes it easier for the public to find accurate info all in one place, starting June 15, 2026. If you interact with the FDA, expect smoother access with no extra costs or delays.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
FDA Centralizes Contact Info Online
If you interact with the FDA, information about the Agency's organization (including central and field offices) and relevant contact information, including email addresses, is available on the FDA website at http://www.fda.gov and in FDA's Staff Manual Guides. This change takes effect June 15, 2026 and directs the public to the Agency website as the uniform, updatable source of organizational and contact information.
No Added Costs or Paperwork Burden
FDA states this rule imposes no costs and contains no collection of information under the Paperwork Reduction Act; the rule lists 'Small Business: None' and declares no state/local/tribal impacts. The rule is effective June 15, 2026, so people and entities that contact FDA should not face new fees, paperwork, or delays because of this change.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-15343, Generic Drug User Fee Rates for Fiscal Year 2027
The Federal Food, Drug, and Cosmetic Act (FD&C Act or statute), as amended by the Generic Drug User Fee Amendments of 2022 (GDUFA III), authorizes the Food and Drug Administration (FDA, Agency, or we) to assess and collect fees for abbreviated new drug applications (ANDAs); drug master files (DMFs); generic drug active pharmaceutical ingredient (API) facilities, finished dosage form (FDF) facilities, and contract manufacturing organization (CMO) facilities; and generic drug applicant program user fees. In this document, FDA is announcing fiscal year (FY) 2027 rates for GDUFA III fees.
2026-15346, Biosimilar User Fee Rates for Fiscal Year 2027
Starting October 1, 2026, companies making biosimilar drugs will pay updated fees to the FDA for developing and getting approval for their products. These fees cover new drug development, application reviews, and yearly program costs. This helps the FDA keep biosimilar drug reviews speedy and fair while supporting innovation.
2026-15335, Medical Device User Fee Rates for Fiscal Year 2027
Starting October 1, 2026, medical device companies will see updated user fees for submitting their products to the FDA and for annual registrations. These fees help the FDA review and monitor medical devices, with special discounts available for small businesses. If you’re in the medical device world, get ready to budget for these new costs through September 30, 2027!
2026-15337, Food Safety Modernization Act Third-Party Certification Program User Fee Rate for Fiscal Year 2027
The Food and Drug Administration (FDA or we) is announcing the fiscal year (FY) 2027 annual fee rate for recognized accreditation bodies and accredited certification bodies, and the initial and renewal fee rate for accreditation bodies applying to be recognized in the third-party certification program authorized by the Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the FDA Food Safety Modernization Act (FSMA). We are also announcing the fee rate for certification bodies applying for direct FDA accreditation.
Previous / Next Documents
Previous: 2026-11993, Security Zone; Santa Monica Bay, Los Angeles, CA
The Coast Guard is setting up a temporary security zone in the waters near Los Angeles International Airport from June 15 to July 12, 2026, to keep everyone safe during the 2026 World Cup. Boats and people can’t enter this area unless they get special permission. This rule helps protect visitors and VIPs without causing delays or extra costs for most folks.
Next: 2026-12011, Miscellaneous Rules Relating to Common Carriers
This update fixes a technical error in the rules for common carriers, especially those handling video relay service (VRS) calls. VRS providers must now double-check who’s on the video side of each call using a special database, except for emergency 911 calls. These changes keep things running smoothly and make sure only eligible users get service—no extra costs or deadlines for you to worry about!